Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | (376.0%) | (460.8%) | (460.0%) | (157.4%) | (361.6%) | 195.5% | (4.1%) | (36.5%) | (32.4%) | (42.4%) | (48.0%) | (47.5%) | (75.6%) | (74.7%) | (113.9%) | (108.2%) | (109.4%) | (126.7%) | (193.2%) | 614.5% |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Microsoft Corp's last 12-month Return on Equity (ROE) is (331.0%), based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Return on Equity (ROE) for Insmed Incorporated have been (657.3%) over the past three years, and (519.0%) over the past five years.
As of today, Insmed Incorporated's Return on Equity (ROE) is (331.0%), which is lower than industry median of (52.7%). It indicates that Insmed Incorporated's Return on Equity (ROE) is Bad.